Four oncology drugs get PBS listings on 1 August

Nivolumab (Opdivo) will be listed on the PBS from 1 August for head and neck squamous cell carcinoma The listing, announced in advance by Federal minister for Health Greg Hunt, means almost 1,000 patients will get subsidised access to the immunotherapy drug they would otherwise have to pay about $50,000 per year for. On 11 ...

Already a member?

Login to keep reading.

© 2021 the limbic